{"entity":{"type":"insider","cik":"0001311634","url":"/insider/0001311634","json_url":"/insider/0001311634.json","name":"Carr Daniel B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2005-11-23","last":"2010-05-05","span_basis":"filed_date"},"name_variants":[{"name":"Carr Daniel B","source":"filing","n_filings":6,"first_seen":"2005-11-23","last_seen":"2010-05-05"}],"transactions":[{"id":7658187,"accession":"0000950117-10-000543","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950117-10-000543","line_url":"/filing/0000950117-10-000543#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001311634","owner_name":"Carr Daniel B","owner_display_name":"Carr Daniel B","owner_url":"/insider/0001311634","role":"Director, Officer (President and CMO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18450.0,"shares_display":"18,450","price_per_share":2.1801,"price_display":"2.18","price_state":"stated","total_value":40222.845,"total_display":"40,222.84","total_whole":"40,223","shares_owned_after":137518.0,"shares_owned_after_display":"137,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-03","filed_date":"2010-05-05","scope":"insider"},{"id":7658185,"accession":"0000950117-10-000388","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950117-10-000388","line_url":"/filing/0000950117-10-000388#line-4","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001311634","owner_name":"Carr Daniel B","owner_display_name":"Carr Daniel B","owner_url":"/insider/0001311634","role":"Director, Officer (President and CMO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":945.0,"total_display":"945.00","total_whole":"945","shares_owned_after":155968.0,"shares_owned_after_display":"155,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-26","filed_date":"2010-03-29","scope":"insider"},{"id":7658180,"accession":"0000950117-10-000388","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950117-10-000388","line_url":"/filing/0000950117-10-000388#line-2","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001311634","owner_name":"Carr Daniel B","owner_display_name":"Carr Daniel B","owner_url":"/insider/0001311634","role":"Director, Officer (President and CMO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4700.0,"shares_display":"4,700","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":6345.0,"total_display":"6,345.00","total_whole":"6,345","shares_owned_after":155901.0,"shares_owned_after_display":"155,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-25","filed_date":"2010-03-29","scope":"insider"},{"id":3746987,"accession":"0001209191-08-030274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-030274","line_url":"/filing/0001209191-08-030274#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"AMEXJAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001311634","owner_name":"Carr Daniel B","owner_display_name":"Carr Daniel B","owner_url":"/insider/0001311634","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20746.0,"shares_display":"20,746","price_per_share":2.41,"price_display":"2.41","price_state":"stated","total_value":49997.86,"total_display":"49,997.86","total_whole":"49,998","shares_owned_after":28746.0,"shares_owned_after_display":"28,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-13","filed_date":"2008-05-15","scope":"insider"},{"id":3928886,"accession":"0000950120-06-000742","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-06-000742","line_url":"/filing/0000950120-06-000742#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"AMEXJAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001311634","owner_name":"Carr Daniel B","owner_display_name":"Carr Daniel B","owner_url":"/insider/0001311634","role":"Director, Officer (CEO & CMO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & CMO","security_title":"Common Stock, $.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":3.45,"price_display":"3.45","price_state":"stated","total_value":13800.0,"total_display":"13,800.00","total_whole":"13,800","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-22","filed_date":"2006-11-27","scope":"insider"},{"id":1521046,"accession":"0000950120-05-000805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-05-000805","line_url":"/filing/0000950120-05-000805#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JVPHOB","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001311634","owner_name":"Carr Daniel B","owner_display_name":"Carr Daniel B","owner_url":"/insider/0001311634","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":6300.0,"total_display":"6,300.00","total_whole":"6,300","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-01","filed_date":"2005-12-05","scope":"insider"},{"id":1472531,"accession":"0000950120-05-000785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-05-000785","line_url":"/filing/0000950120-05-000785#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JVPH.OB","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001311634","owner_name":"Carr Daniel B","owner_display_name":"Carr Daniel B","owner_url":"/insider/0001311634","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":6200.0,"total_display":"6,200.00","total_whole":"6,200","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-22","filed_date":"2005-11-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000050710","name":"JAVELIN PHARMACEUTICALS, INC","url":"/issuer/0000050710","role":"Director, Officer (President and CMO)","n_filings":6,"first_seen":"2005-11-23","last_seen":"2010-05-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001311634","retrieved_at":"2026-08-25T19:06:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}